Name: Biology, Treatment and Genetic Epidemiology of Pediatric ALL (en Inglés)
Price: 57.26 USD
Availability: InStock
Author: Alanazi, Nawaf ; Awan Khalid, Tashfeen ; Iqbal, Zafar
ISBN: 9786202816328

portada Biology, Treatment and Genetic Epidemiology of Pediatric ALL (en Inglés)

Biology, Treatment and Genetic Epidemiology of Pediatric ALL (en Inglés)

Formato

Libro Físico

Autor

Zafar Iqbal

Nawaf Alanazi

Tashfeen Awan Khalid

Editorial

LAP Lambert Academic Publishing

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.5 cm

Peso

0.14 kg.

ISBN13

9786202816328

Categorías

Veterinaria

Biology, Treatment and Genetic Epidemiology of Pediatric ALL (en Inglés)

Zafar Iqbal (Autor) · Nawaf Alanazi (Autor) · Tashfeen Awan Khalid (Autor) · LAP Lambert Academic Publishing · Tapa Blanda

Libro Nuevo Importado

Envío: 25 a 32 días háb.

$ 104.12$ 57.26

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 57.26

Llega entre el 08 Sep y el 21 Sep a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Biology, Treatment and Genetic Epidemiology of Pediatric ALL (en Inglés)"

Acute Lymphoblastic Leukemia is the most common childhood malignancy with over 80% cure rates in most parts of the world. Nevertheless, genetic abnormalities that are the major prognostic and determinants of treatment decision-making are not uniformly distributed in different geographic regions of the word, specifically fusion oncogenes. This is due to ethnic differences, racial and environmental variations, population mixing and delayed exposure to infection and drastic difference of socio-economic status. Because of huge clinical implications of genetics in pediatric ALL, it is one of the major contributing factors of disparities in ALL cure rates between developed world and developing countries. Therefore, cost-effective genetic testing should be part of routine clinical decision making in underdeveloped countries. Moreover, state-of-the-art genomic technologies should be employed to further explore variations in genetic epidemiology of ALL and its impact on differential diagnosis, prognostic stratification and therapeutic decision-making.